Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ludiomil 10mg tablets
0403010S0BBAAAA
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Ludiomil 25mg tablets
0403010S0BBABAB
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Ludiomil 50mg tablets
0403010S0BBACAE
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Ludiomil 75mg tablets
0403010S0BBADAD
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 10mg tablets
0403010S0AAAAAA
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 25mg tablets
0403010S0AAABAB
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 50mg tablets
0403010S0AAAEAE
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 75mg tablets
0403010S0AAADAD
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.